Advertisement
For patients with allergic rhinitis

Grass Pollen SLIT Slows Course of Allergic Rhinitis, Asthma

0
Tx associated with slower AR progression, less frequent asthma onset, slower asthma progression
Administration of allergen immunotherapy in patients with allergic asthma leads to lower short-term symptom and medication scores

Short-Term Benefits for Immunotherapy in Allergic Asthma

0
Reductions seen in short-term symptom scores and medication scores, with evidence of publication bias
For effective hand hygiene

Cool Water Works As Well As Hot for Ridding Hands of Germs

0
Time spent scrubbing hands with soap more important that water temperature
Americans are routinely overcharged for emergency department care

U.S. Emergency Departments Commonly Overcharging Patients

0
Minorities and uninsured are the most affected, researchers say

May 2017 Briefing – Pulmonology

0
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for May 2017. This roundup includes the latest...
Certain plasma microRNAs are differentially regulated in allergic asthma and correlate with clinical characteristics

MicroRNA Biomarker Signature Identified for Allergic Asthma

0
Biomarker signature with seven miRNAs identified in training cohort of 20 asthma patients, nine controls
An appointment-based model which synchronizes medication refills to improve medication adherence is associated with improvement in medication-taking behavior

Medication Adherence Up With Refill Synchronization Model

0
Improvement in medication-taking behavior; cost savings over one year for HTN, DM, hyperlipidemia
Excess weight is associated with increased costs across health care settings

Excess Weight Increases Costs Across Health Care Settings

0
Percentage increases in costs associated with obesity were highest for medications, higher for women
Vancomycin can be modified to make it much more potent against resistant bacterial infections

Modified Vancomycin May Help Fight Bacterial Resistance

0
New form of vancomycin attacks bacteria in three ways, helping curb threat of microbial resistance
Restarting anticoagulation therapy may be cost-effective for patients with a predicted one-year venous thromboembolism risk of 17.5 percent or higher

Restarting Anticoagulation in Certain VTE Cases Cost-Effective

0
Treating patients with predicted VTE risk of 17.5 percent or more may be cost-effective